Abstract Body

Background: Lymphoid tissue fibrosis occurs early in HIV infection and is thought to be a central factor in the pathogenesis of HIV by impairing T cell homeostasis. Collagen deposition is a dynamic process, and traditional histologic techniques cannot distinguish between new collagen deposition and any fibrosis that may have accumulated during the untreated phase of HIV infection. We investigated the use of a technique utilizing 2H2O (heavy water) intake to quantify new collagen deposition in gut-associated lymphoid tissue (GALT) in treated HIV-infected individuals.

Methods: Eighteen HIV-infected individuals on suppressive ART received outpatient oral doses of 2H2O for 4 weeks and underwent colorectal biopsies. 2H2O enrichment in total body water (TBW) in each patient was quantified from weekly salivary swabs during 2H2O administration. Single 3mm biopsy pieces were subjected to sequential physical and chemical extraction methods to fractionate collagen molecules based on solubility in guanidine HCl. Guanidine-soluble collagen represents more recently synthesized, less cross-linked collagen. Incorporation of the 2H2O tracer into collagen in GALT was quantified by liquid-chromatography-mass spectrometry and fractional synthesis rate (FSR; per week) was calculated for guanidine-soluble and -insoluble GALT collagen.

Results: Outpatient administration of 2H2O was well tolerated. After 28 days of 2H2O intake, subjects reached the target goal of 1-2% 2H2O enrichment in TBW. The median FSR of guanidine-insoluble collagen in GALT was 3.2% per week (IQR 2.9%-3.9%). Guanidine-soluble collagen in GALT turned over much more quickly, with a median FSR of 12.8% per week (IQR 12.3%-16.1%). In comparison with other human studies where collagen FSR was measured by 2H2O labeling, the FSRs in GALT were 5-fold higher than the FSRs of skin collagen in healthy volunteers but similar to the FSR of liver collagen in patients with fibrotic liver disease.

Conclusions: The relatively high rates of collagen turnover observed in the GALT during treated HIV disease (guanidine soluble collagen half-life ~ 5 weeks) suggest that collagen deposition and turnover is ongoing and dynamic in this setting, and may therefore be amenable to interventions. The 2H2O labeling technique provides an assessment of collagen turnover rates, in contrast to static metrics from traditional histologic techniques, and may be useful for evaluating the effects of future anti-fibrotic therapies.